Filter
439
Filtered Results: 439
Text search:
prevalence
of
epilepsy
Featured
Recommendations
47
New Publications
93
Language
Document type
No document type
321
Studies & Reports
46
Guidelines
29
Manuals
19
Strategic & Response Plan
11
Training Material
6
Fact sheets
4
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
21
Uganda
17
South Africa
17
Kenya
14
Sierra Leone
12
Liberia
10
Zambia
10
Malawi
10
Global
10
Nigeria
9
Nepal
9
Ethiopia
8
Bangladesh
8
Rwanda
6
Lesotho
6
Latin America and the Carribbean
6
Ghana
5
Ukraine
5
Asia
5
Cambodia
4
South–East Asia Region
4
Western and Central Europe
4
Africa
4
Congo, Democratic Republic of
3
Syria
3
Tanzania
3
Mozambique
3
Botswana
3
Russia
3
Cameroon
2
Zimbabwe
2
Pakistan
2
South Sudan
2
Sudan
2
Myanmar / Burma
2
Chile
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Senegal
1
Mali
1
USA
1
Haiti
1
Philippines
1
Turkey
1
Egypt
1
Thailand
1
China
1
Indonesia
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Colombia
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
175
Public Health
23
Clinical Guidelines
18
Women & Child Health
9
Capacity Building
6
Key Resources
3
Toolboxes
Mental Health
144
Disability
79
NTDs
13
Planetary Health
11
NCDs
9
Conflict
6
HIV
6
TB
6
Pharmacy
6
Global Health Education
5
Caregiver
5
Refugee
3
Ebola
2
Natural Hazards
2
Zika
2
AMR
2
COVID-19
2
Rapid Response
1
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because ... the impact of epilepsy on wages, health costs and social stigmatization of sufferers. Health systems are also burdened as treatments must be tailored to individual needs.
The Global Campaign Against Epilepsy “Out of the Shadows”
Published OnlineJuly 14, 2021https://doi.org/10.1016/S2214-109X(21)00164-9. New Lancet research offers the first comprehensive analysis of the growing footprint of noncommunicable and injury-related...
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at...
The purpose of the situation assessment was to execute a situation analysis for Autism and Neurodevelopment Disorder (NDD) in Bangladesh. The situation assessment covers the following areas: a review of...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired ep... in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of Taenia solium. The parasite is most prevalent in poor and vulnerable communities in which pigs roam free, open defecation is practiced, basic sanitation is deficient, and health education is absent or limited. Several tools are available for the control of Taenia solium. Preventive chemotherapy for Taenia solium taeniasis, which is directed at the adult tapeworm, is one of them. Other tools focus on pig management, pig vaccination and treatment, sanitation and hygiene, and community education. Three potential drugs—niclosamide, praziquantel, and albendazole—have been considered for use for preventive chemotherapy in Taenia solium taeniasis control programs through mass drug administration or targeted chemotherapy. In this Guideline, we provide recommendations for preventive chemotherapy in Taenia solium-endemic areas using niclosamide, praziquantel, or albendazole, including at which dose and in which population groups.
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate...
BMC Medicine201210:107
https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012
Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012
In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r...
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidl...
Haiti, one of the poorest countries in the world, was devastated by an earthquake in 2010. The disaster uncovered the realities of a non-existent mental health care system with only ten psychiatrist...
Mental health problems are common and cause great suffering to individuals and communities around the world. They have a significant impact not only on the physical and mental health of those affected but also on their families and the communities t...
Low- and middle-income countries (LMICs) experience a high disease burden for epilepsy, a chronic neurological condition.The authors evaluate the cost-effectiveness of community health workers (CHWs...
Global Report on assistive technology
recommended
The report notes that the number of people in need of one or more assistive products is likely to rise to 3.5 billion by 2050, due to populations ageing and the ... of noncommunicable diseases rising across the world. The report also highlights the vast gap in access between low- and high-income countries. An analysis of 35 countries reveals that access varies from 3% in poorer nations to 90% in wealthy countries.
Affordability is a major barrier to access, the report notes. Around two thirds of people with assistive products reported out-of-pocket payments for them. Others reported relying on family and friends to financially support their needs.
This article describes a Community-Based Participatory Approach (CBPA) for children with intellectual disability in Endosulfan affected areas of Kasaragod district in Kerala state of India. The CBPA...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions ... Africa [1, 2], but currently the exact distribution remains unclear. Reported prevalences of T. solium taeniosis and cysticercosis in African countries are not extensive and are further complicated by the lack of ‘gold standard’ tests for diagnosis.
This document adopts a health determinants framework for examining the evidence related to women’s poor mental health. From this perspective, public policy including economic policy, socio-cultural and environmental factors, community and social support, stressors and life events, personal behavio...
ALTER, European Journal of Disability Research 9(2015)317–330.
The purpose of this paper is to describe the varying scope and content of data co...
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management ... febrile seizures by non-specialists in low and middle income settings? For prophylaxis to prevent recurrence of simple or complex febrile seizures, which of the pharmacological interventions when compared with placebo/comparator produce benefit/harm in specified outcomes?
- continuous anticonvulsant therapy - intermittent anticonvulsant therapy - intermittent antipyretic treatment
Reflections from disability research using the ICF in Afghanistan and Cambodia | Working Paper Series: No. 11
